Anterior vs Xsolis (2026)
Both apply AI to the decision about whether care is necessary, and they stand in different places while doing it. Anterior builds for health plans, completing cases automatically only where criteria are clearly met and sending the rest to a clinician. Xsolis sits between payer and provider, continuously scoring medical necessity so that both sides argue from the same number, with peer reviewed research behind its score and a stated HITRUST certification. That shared score is the more interesting proposition, because the dispute in utilization management is usually about the evidence rather than the rules. Neither publishes a bias evaluation, and here the output can end in care being denied.
- It is built for health plans specifically, applying clinical AI to the review decision itself rather than to the medical necessity score underneath it.
- Work completes automatically only where criteria are clearly met and the rest goes to a clinician; the company says licensed clinicians make every final determination and that the AI will never deny care.
- For a plan whose bottleneck is nurse and physician review capacity, a product aimed at that queue is more directly useful than a shared score.
- It sits between payer and provider rather than serving one side, which is a genuinely different position in utilization management and changes what both parties can argue about.
- Peer reviewed research on its score is published from studies across several United States health systems.
- It states HITRUST risk based certification at the two year tier.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. Anterior and Xsolis are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | Anterior | Xsolis |
|---|---|---|
| Primary category | RCM & Prior Auth AI | RCM & Prior Auth AI |
| Founded | 2022 | 2013 |
| Headquarters | New York, New York, United States | Franklin, Tennessee |
| Website | anterior.com | xsolis.com |
Side by Side
Select any grade to read the note behind it.
Product updates
The latest logged changes from each vendor, newest first, each linked to its source.
Anterior
-
Model / architecture
Anterior open sourced a research preview of its symbolic reasoning library and an MCP server under the Apache 2.0 license.
Source
Xsolis
-
Product / capability
Xsolis launched GenAI Peer-to-Peer Clinical Synopsis as an add on inside Dragonfly Advise.
Source
Each vendor in one paragraph
Written to be quoted whole. Each paragraph opens the AI Health Index profile of the vendor: what the product is, who buys it and what it does.
Anterior sells clinical AI to health plans and to the organizations that run clinical review for them. Its system, Florence, is built on frontier models and reads charts, faxes, structured feeds and policy text to support utilization management and prior authorization, case management, HEDIS gap closure, risk adjustment, payment integrity, policy management, and appeals and grievances, packaged as four programs: Triage, Flow, Relay and Steward.
Source: AI Health Index, September 2026
Xsolis sells AI utilization management to hospitals and health plans. Its Dragonfly platform scores each admitted patient's likelihood of needing inpatient care or observation, using machine learning over the hospital record, so the hospital and the payer can work from the same clinical evidence when they decide status and concurrent authorization.
Source: AI Health Index, September 2026
Questions buyers ask
How do Anterior and Xsolis work with the EHR?
For Anterior, the Florence page says the system uses FHIR internally and ingests X12 EDI, HL7 v2, C-CDA, NCPDP, SFTP extracts, proprietary feeds and unstructured PDFs, faxes and scans, with documented SDKs and APIs for common plan systems and bespoke paths where needed; accepting fax and scan is what reaches a whole provider network.
With Xsolis, the shared clinical access between a health system and its payers through Dragonfly is a distinct integration pattern, since both parties read the same record view. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 22, 2026. No vendor pays for placement.
How are Anterior and Xsolis priced and sold?
In Anterior's case, the difference matters in utilization management, where a fee per determination rewards volume.
For Xsolis, the offering is a hybrid: alongside the platform the company sells Physician Advisor Services covering night and weekend gaps or operating fully outsourced, so the buy can be software, staffed service, or both. A clinical staffing component behaves very differently from a license. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 22, 2026. No vendor pays for placement.
How do Anterior and Xsolis handle patient data?
With Anterior, the Florence page says feedback from language model checks and human review flows back into the system so Florence keeps improving with every case, and that each plan's decision standards are encoded and version controlled.
Xsolis announced HITRUST r2 certification for the platform in March 2022 and described it as a proactive approach to protecting health information; the website privacy policy covers site visitors only. Nothing published states how long clinical data drawn from hospital records is kept, whether it is de identified, or whether it trains the Care Level Score. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 22, 2026. No vendor pays for placement.
What evidence is published for Anterior and Xsolis?
For Anterior, the home and Florence pages report that MedWatch, a national utilization management organization, achieved three times clinician productivity across utilization management, care management and payment integrity work, with 92 percent satisfaction and 97 percent clinical accuracy.
With Xsolis, the Care Level Score predicted inpatient discharge status with an area under the curve of 0.89, and a score of 76 or higher classified status correctly 86 percent of the time. Combining the score with a commercial screening tool did worse than the score alone. From the AI Health Index, drawn from each vendor's own published materials and the regulatory record, verified September 22, 2026. No vendor pays for placement.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the RCM & Prior Auth AI page.
In utilization management an AI output can result in care being denied, and neither vendor publishes a bias evaluation or subgroup performance analysis. Washington's rule on prior authorization states that a carrier is not exempt from compliance because it used a third party vendor and requires the program to meet a national accreditation standard, so vendor accreditation transfers benefit and its absence transfers burden.
Anterior holds no such accreditation; it names SOC 2 Type II and HITRUST on its site, with the reports behind a trust center, and says little about where the service is hosted. Neither vendor publishes pricing, and Xsolis additionally sells a physician advisory service alongside the platform, which is a different commercial shape from software alone.